资讯
AiViva Biopharma Completes Enrollment in a Phase 1 Clinical Trial of AIV007 for Age-Related Macular
Novel JEL™ Technology for Periocular Administration
COSTA MESA, Calif., Aug. 23, 2024 (GLOBE NEWSWIRE) - AiViva Biopharma Inc., a clinical-stage biotechnology company, announced that it has fully...